A detailed history of Two Sigma Investments, LP transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 33,302 shares of ARWR stock, worth $839,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,302
Previous 25,902 28.57%
Holding current value
$839,876
Previous $792,000 20.2%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$27.21 - $39.48 $201,354 - $292,152
7,400 Added 28.57%
33,302 $952,000
Q4 2023

Feb 14, 2024

SELL
$21.2 - $31.03 $5.13 Million - $7.51 Million
-242,032 Reduced 90.33%
25,902 $792,000
Q3 2023

Nov 14, 2023

SELL
$26.2 - $36.08 $1.13 Million - $1.56 Million
-43,106 Reduced 13.86%
267,934 $7.2 Million
Q2 2023

Aug 14, 2023

BUY
$25.16 - $41.38 $5.55 Million - $9.13 Million
220,740 Added 244.45%
311,040 $11.1 Million
Q1 2023

May 15, 2023

BUY
$23.68 - $38.51 $1.81 Million - $2.94 Million
76,355 Added 547.54%
90,300 $2.29 Million
Q4 2022

Feb 14, 2023

BUY
$28.0 - $40.56 $390,460 - $565,609
13,945 New
13,945 $565,000
Q2 2022

Aug 15, 2022

BUY
$27.79 - $50.61 $1.01 Million - $1.83 Million
36,257 Added 546.95%
42,886 $1.51 Million
Q1 2022

May 16, 2022

BUY
$39.62 - $69.97 $262,640 - $463,831
6,629 New
6,629 $305,000
Q3 2021

Nov 15, 2021

SELL
$58.38 - $84.96 $4.33 Million - $6.3 Million
-74,200 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$62.15 - $90.32 $1.39 Million - $2.02 Million
22,338 Added 43.07%
74,200 $6.15 Million
Q1 2021

May 17, 2021

BUY
$61.35 - $90.47 $3.18 Million - $4.69 Million
51,862 New
51,862 $3.44 Million
Q3 2020

Nov 16, 2020

SELL
$33.21 - $51.27 $1.06 Million - $1.63 Million
-31,787 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$26.12 - $43.27 $14.1 Million - $23.4 Million
-540,616 Reduced 94.45%
31,787 $1.37 Million
Q1 2020

May 15, 2020

BUY
$20.56 - $63.12 $8.55 Million - $26.3 Million
415,952 Added 265.87%
572,403 $16.5 Million
Q4 2019

Feb 14, 2020

BUY
$28.14 - $73.01 $4.4 Million - $11.4 Million
156,451 New
156,451 $9.92 Million
Q4 2018

Feb 14, 2019

SELL
$10.74 - $19.7 $2.53 Million - $4.63 Million
-235,216 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$14.0 - $20.3 $3.29 Million - $4.77 Million
235,216 New
235,216 $4.51 Million
Q2 2018

Aug 14, 2018

BUY
$6.37 - $14.02 $1.2 Million - $2.64 Million
188,364 New
188,364 $2.56 Million
Q1 2018

May 15, 2018

SELL
$3.72 - $7.64 $147,780 - $303,506
-39,726 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$3.14 - $4.5 $124,739 - $178,767
39,726
39,726 $146,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.67B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.